The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Giant-Cell Arteritis and Polymyalgia Rheumatica
Open accessAbstract
Both giant-cell arteritis and polymyalgia rheumatica are immune-mediated diseases that are treated with glucocorticoids, with higher doses used for giant-cell arteritis. Prompt initiation of high doses and a biopsy are recommended when ischemic optic neuropathy is suspected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Hunder, G. G., Bloch, D. A., Michel, B. A., Stevens, M. B., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., Lie, J. T., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330810 · Cited by 2,539
Medium- and Large-Vessel Vasculitis
Weyand, C. M., & Goronzy, J. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022694 · Cited by 788
Self-citationGrossman, J. M., Gordon, R., Ranganath, V. K., Deal, C., Caplan, L., Chen, W., Curtis, J. R., Furst, D. E., McMahon, M., Patkar, N. M., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20295 · Cited by 708
EULAR recommendations for the management of large vessel vasculitis
Mukhtyar, C. B., Guillevin, L., Cid, M. C., Dasgupta, B., de Groot, K., Gross, W. L., Hauser, T., Hellmich, B., Jayne, D. R. W., Kallenberg, C. G. M., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.088351 · Cited by 673
Crowson, C. S., Matteson, E. L., Myasoedova, E., Michet, C. J., Ernste, F. C., Warrington, K. J., Davis, J. M., Hunder, G. G., Therneau, T. M., & Gabriel, S. E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30155 · Cited by 638
Mahr, A. D., Jover, J. A., Spiera, R. F., Hernández‐García, C., Fernández‐Gutiérrez, B., LaValley, M. P., & Merkel, P. A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22754 · Cited by 622
Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
Proven, A., Gabriel, S. E., Orces, C., O'Fallon, W. M., & Hunder, G. G. (2003) · Arthritis Care & Research · doi:10.1002/art.11388 · Cited by 612
Epidemiology of giant cell arteritis and polymyalgia rheumatica
Gonzalez‐Gay, M. A., Vazquez‐Rodriguez, T. R., Lopez‐Diaz, M. J., Miranda‐Filloy, J. A., Gonzalez‐Juanatey, C., Martin, J., & Llorca, J. (2009) · Arthritis Care & Research · doi:10.1002/art.24459 · Cited by 576
Hoffman, G. S., Cid, M. C., Rendt-Zagar, K. E., Merkel, P. A., Weyand, C. M., Stone, J. H., Salvarani, C., Xu, W., Visvanathan, S., Rahman, M. U., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00004 · Cited by 563
Self-citationBSR and BHPR guidelines for the management of giant cell arteritis
Dasgupta, B., Borg, F. A., Hassan, N., Alexander, L., Barraclough, K., Bourke, B., Fulcher, J., Hollywood, J., Hutchings, A., James, P., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq039a · Cited by 444
Th17 and Th1 T-Cell Responses in Giant Cell Arteritis
Deng, J., Younge, B. R., Olshen, R. A., Goronzy, J. J., & Weyand, C. M. (2010) · Circulation · doi:10.1161/circulationaha.109.872903 · Cited by 435
Self-citationDasgupta, B., Cimmino, M. A., Kremers, H. M., Schmidt, W. A., Schirmer, M., Salvarani, C., Bachta, A., Dejaco, C., Duftner, C., Jensen, H. S., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34356 · Cited by 413
Immune mechanisms in medium and large-vessel vasculitis
Weyand, C. M., & Goronzy, J. J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.161 · Cited by 412
Self-citationVisual Prognosis in Giant Cell Arteritis
Aiello, P. D., Trautmann, J. C., McPhee, T. J., Kunselman, A. R., & Hunder, G. G. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31608-8 · Cited by 388
Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study.
De Silva, M., & Hazleman, B. L. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.2.136 · Cited by 360
Mazlumzadeh, M., Hunder, G. G., Easley, K. A., Calamia, K. T., Matteson, E. L., Griffing, W. L., Younge, B. R., Weyand, C. M., & Goronzy, J. J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22163 · Cited by 347
Self-citationRoche, N. E., Fulbright, J. W., Wagner, A. D., Hunder, G. G., Goronzy, J. J., & Weyand, C. M. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360913 · Cited by 347
Self-citationVessel-Specific Toll-Like Receptor Profiles in Human Medium and Large Arteries
Pryshchep, O., Ma-Krupa, W., Younge, B. R., Goronzy, J. J., & Weyand, C. M. (2008) · Circulation · doi:10.1161/circulationaha.108.789172 · Cited by 323
Self-citationKermani, T. A., Warrington, K. J., Crowson, C. S., Ytterberg, S. R., Hunder, G. G., Gabriel, S. E., & Matteson, E. L. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202408 · Cited by 321
Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity
Weyand, C. M., Fulbright, J. W., Hunder, G. G., Evans, J. M., & Goronzy, J. J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1041::aid-anr12>3.0.co;2-7 · Cited by 299
Self-citationUnizony, S., Arias‐Urdaneta, L., Miloslavsky, E., Arvikar, S., Khosroshahi, A., Keroack, B., Stone, J. R., & Stone, J. H. (2012) · Arthritis Care & Research · doi:10.1002/acr.21750 · Cited by 272
BSR and BHPR guidelines for the management of polymyalgia rheumatica
Dasgupta, B., Borg, F. A., Hassan, N., Barraclough, K., Bourke, B., Fulcher, J., Hollywood, J., Hutchings, A., Kyle, V., Nott, J., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/kep303a · Cited by 251
Clinical features of polymyalgia rheumatica and giant cell arteritis
Salvarani, C., Pipitone, N., Versari, A., & Hunder, G. G. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.97 · Cited by 227
Salvarani, C., Macchioni, P., Manzini, C., Paolazzi, G., Trotta, A., Manganelli, P., Cimmino, M., Gerli, R., Catanoso, M. G., Boiardi, L., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00005 · Cited by 199
Besson, F. L., Parienti, J.-J., Bienvenu, B., Prior, J. O., Costo, S., Bouvard, G., & Agostini, D. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1830-0 · Cited by 195
Rapid induction of remission in large vessel vasculitis by IL-6 blockade
Seitz, M., Reichenbach, S., Bonel, H., Adler, S., Wermelinger, F., & Villiger, P. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13156 · Cited by 190
Role of ultrasonography in the diagnosis of temporal arteritis
Ball, E. L., Walsh, S. R., Tang, T. Y., Gohil, R., & Clarke, J. M. F. (2010) · British Journal of Surgery · doi:10.1002/bjs.7252 · Cited by 180
Kermani, T. A., & Warrington, K. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60680-1 · Cited by 172
Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis
DASGUPTA, B., & PANAYI, G. S. (1990) · Rheumatology · doi:10.1093/rheumatology/29.6.456 · Cited by 171
Hauenstein, C., Reinhard, M., Geiger, J., Markl, M., Hetzel, A., Treszl, A., Vaith, P., & Bley, T. A. (2012) · Rheumatology · doi:10.1093/rheumatology/kes153 · Cited by 170
Matteson, E. L., Gold, K. N., Bloch, D. A., & Hunder, G. G. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89458-2 · Cited by 150
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
Weyand, C. M., Younge, B. R., & Goronzy, J. J. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833ee946 · Cited by 140
Self-citationThe Immunopathology of Giant Cell Arteritis
Weyand, C. M., Liao, Y. J., & Goronzy, J. J. (2012) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e318268aa9b · Cited by 131
Self-citationIncreased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica
Kreiner, F. F., Langberg, H., & Galbo, H. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27728 · Cited by 72
Statin Use in Giant Cell Arteritis: A Retrospective Study
Schmidt, J., Kermani, T. A., Muratore, F., Crowson, C. S., Matteson, E. L., & Warrington, K. J. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121150 · Cited by 58
Yates, M. M., Loke, Y. K., Watts, R. A., & MacGregor, A. J. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2384-2 · Cited by 53
Maldini, C., DÉPINAY-DHELLEMMES, C., TRA, T. T. S., CHAUVEAU, M., Allanore, Y., Gossec, L., TERRASSE, G., Guillevin, L., Coste, J., & Mahr, A. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100353 · Cited by 52
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Maz, M., Chung, S. A., Abril, A., Langford, C. A., Gorelik, M., Guyatt, G., Archer, A. M., Conn, D. L., Full, K. A., Grayson, P. C., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41774 · Cited by 654
Villiger, P. M., Adler, S., Kuchen, S., Wermelinger, F., Dan, D., Fiege, V., Bütikofer, L., Seitz, M., & Reichenbach, S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00560-2 · Cited by 577
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review
Buttgereit, F., Dejaco, C., Matteson, E. L., & Dasgupta, B. (2016) · JAMA · doi:10.1001/jama.2016.5444 · Cited by 496
A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis
Langford, C. A., Cuthbertson, D., Ytterberg, S. R., Khalidi, N., Monach, P. A., Carette, S., Seo, P., Moreland, L. W., Weisman, M., Koening, C. L., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40044 · Cited by 394
Azoulay, E., Lemiale, V., Mokart, D., Nseir, S., Argaud, L., Pène, F., Kontar, L., Bruneel, F., Klouche, K., Barbier, F., et al. (2018) · JAMA · doi:10.1001/jama.2018.14282 · Cited by 333
Metadata
- Authors
- Weyand, C. M., & Goronzy, J. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-07-03
- Volume
- 371
- Issue
- 1
- Pages
- 50-57
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2537085646
- Cited by
- 410
- References
- 38
- FWCI
- 27.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.